-
Identification of novel genes causing intracranial aneurysms
https://braincanada.ca/fr/subventions-financées/identification-of-novel-genes-causing-intracranial-aneurysmsStroke is the leading cause of disability among adults and one of the three leading causes of death in North America. Project Overview Stroke is the leading cause of disability among adults and one of the three leading causes of death in North America. Intracranial aneurysm (IA) is one of the main...
-
Identification of Protein Interactions That Regulate FUS Mislocalization and Aggregation in ALS
https://braincanada.ca/fr/subventions-financées/identification-of-protein-interactions-that-regulate-fus-mislocalization-and-aggregation-in-alsAmyotrophic lateral sclerosis (ALS) is a debilitating and terminal disease. Project Overview Amyotrophic lateral sclerosis (ALS) is a debilitating and terminal disease. A common hallmark of its familial and sporadic forms is the accumulation of insoluble protein aggregates in the cytoplasm of motor...
-
Identification of the Neural Circuitry of Persistent Depressive Symptoms in First-Episode Schizophrenia: From Biomarkers to Predictive Imaging
https://braincanada.ca/fr/subventions-financées/identification-of-the-neural-circuitry-of-persistent-depressive-symptoms-in-first-episode-schizophrenia-from-biomarkers-to-predictive-imagingPeople with schizophrenia often suffer from depressive and negative symptoms, such as reduced emotional expression, or less motivation. Project Overview People with schizophrenia often suffer from depressive and negative symptoms, such as reduced emotional expression, or less motivation. These...
-
Identifying Proteogenomic Signatures Of Smoldering Lesions in Multiple Sclerosis
https://braincanada.ca/fr/subventions-financées/identifying-proteogenomic-signatures-of-smoldering-lesions-in-multiple-sclerosisMultiple sclerosis (MS) is the most common cause of non-traumatic neurological disability, affecting 1 in 400 Canadian adults. Project Overview Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability, affecting 1 in 400 Canadian adults. It occurs when the immune...
-
Identifying the cell-type specific transcriptional program by Npas4 in motor learning
https://braincanada.ca/fr/subventions-financées/identifying-the-cell-type-specific-transcriptional-program-by-npas4-in-motor-learningThe primary motor cortex in the brain is responsible for voluntary movement. It has also been proposed to be one of the sites for motor memory formation and storage. Project Overview The primary motor cortex in the brain is responsible for voluntary movement. It has also been proposed to be one of...
-
Igniting Hope : tisser des liens, apprendre et bâtir un avenir meilleur pour la santé mentale des jeunes au Canada
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/igniting-hope-favorise-l-apprentissage-par-connexion-et-la-promesse-d-un-avenir-meilleur-pour-la-santé-mentale-des-jeunes-au-canadaLe 15 novembre dernier à Toronto, la Fondation Brain Canada a réuni, avec le soutien de la RBC, plus de 70 jeunes leaders, militants, cliniciens, chercheurs, décideurs et intervenants autour d’une discussion essentielle sur la santé mentale des jeunes. Le 15 novembre dernier à Toronto, la Fondation...
-
Il faut agir dès maintenant. Accélérons la recherche en santé mentale des jeunes au Canada
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/il-est-temps-d-agir-il-faut-accélérer-la-recherche-sur-la-santé-mentale-des-jeunes-au-canadaLa Fondation RBC appuie le lancement de la plateforme en santé mentale des jeunes de la Fondation Brain Canada grâce à un don de 2 millions de dollars La Fondation RBC appuie le lancement de la plateforme en santé mentale des jeunes de la Fondation Brain Canada grâce à un don de 2 millions de...
-
Imaging a New ALS Biomarker in the Eye
https://braincanada.ca/fr/subventions-financées/imaging-a-new-als-biomarker-in-the-eyeCurrent biomarkers of ALS used by clinicians to help care for ALS patients have many drawbacks that may include cost, accessibility, and invasiveness of procedures. Project Overview Current biomarkers of ALS used by clinicians to help care for ALS patients have many drawbacks that may include cost,...
-
Imaging Endocannabinoid Signalling in Individuals with Cocaine Addiction
https://braincanada.ca/fr/subventions-financées/imaging-endocannabinoid-signalling-in-individuals-with-cocaine-addictionCocaine is a highly addictive stimulant drug. Approximately 10% of Canadians aged 20-24 report current cocaine use. Project Overview Cocaine is a highly addictive stimulant drug. Approximately 10% of Canadians aged 20-24 report current cocaine use. Demand for the drug is growing and rates of...
-
Immunotherapy as a targeted low-impact treatment of paediatric brain cancers
https://braincanada.ca/fr/subventions-financées/immunotherapy-as-a-targeted-low-impact-treatment-of-paediatric-brain-cancersThe existing treatment regimens for children with ependymomas are generally not successful and if successful survivors are left with considerable disabilities including severely diminished IQ, focal neurological and language deficits, and endocrine deficiencies. Project Overview The existing...